Position in ABBV
as of Mar 31, 2026
· filed Apr 9, 2026
Position Value
$19,615,423
-$315,531 QoQ
Shares Held
90,190
+3.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
2.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026TruWealth Advisors, LLC holds $85,956,222 across 7 Drug Manufacturers - General names. ABBV ranks #2 (22.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,900 | $33,019,743 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
90,190 | $19,615,423 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
257,538 | $15,619,679 | |
| 4 | GSK |
GSK plc
|
269,102 | $14,851,739 | |
| 5 | JNJ |
Johnson & Johnson
|
5,451 | $1,332,442 | |
| 6 | PFE |
Pfizer Inc
|
36,369 | $1,021,241 | |
| 7 | MRK |
Merck & Co., Inc.
|
4,123 | $495,955 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,615,423 | 90,190 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $19,930,954 | 87,229 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $34,238,514 | 147,873 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $26,461,430 | 142,557 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $28,236,381 | 134,767 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $28,012,805 | 157,641 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $30,901,867 | 156,481 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $26,467,251 | 154,310 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $27,383,469 | 150,376 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $23,159,336 | 149,444 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $21,877,387 | 146,769 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $19,205,492 | 142,548 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $19,028,140 | 119,396 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $22,718,002 | 140,573 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $18,847,512 | 140,433 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $20,877,086 | 136,309 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $21,324,111 | 131,541 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $17,663,200 | 130,452 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $13,285,592 | 123,163 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $13,284,536 | 117,938 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $8,290,409 | 76,607 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $7,654,581 | 71,438 | Shares | Sole | 2021-01-26 | |
| No filing history on record for this holder in this stock. | ||||||